We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Radiofrequency Ablation Can Destroy Lung Tumors

By HospiMedica staff writers
Posted on 10 Aug 2004
Radiofrequency ablation (RFA), the utilization of electrodes to heat and eradicate abnormal tissue, is a promising method to safely and successfully treat patients with inoperable lung tumors, according to a recent Italian study.

In a study of 18 patients with lung tumors not eligible for surgery, 40 nodules were treated by lung RFA. More...
On regular follow-up, no relapse was detected in 94% of the patients. The study was published in the August 2004 issue of the American Journal of Roentgenology.

According to Cosmo Gadaleta, M.D., from the IRCCS Hospital of Oncology (Bari, Italy), a lead author of the study, most lung tumors are inoperable because of coexisting health problems or poor respiratory function in the patient. A number of these kinds of inoperable tumors have been treated using radiotherapy, which can cause serious toxicity in a patient, and chemotherapy, which is not tolerable by all patients.

"Lung RFA can get around all those problems. It is minimally invasive, with only a small needle being inserted into the patient. It is also advantageous because of potentially low costs, short hospitalization times, and good patient tolerance without mortality, stated Dr. Gadaleta.

Complications caused by lung RFA were minor and included pneumothorax. Pneumothorax occurred in a small percentage of cases, and each occurrence was treated successfully with pleural drainage, according to Dr. Gadaleta. "The risk is small when compared to the benefits of lung RFA, and since the radiology team anticipates the possibility of pneumothorax developing as a result of the procedure, they carefully monitor the patient so they can quickly treat any complications.”

Dr. Gadaleta also stated that lung RFA is a promising technique for treating patients with certain operable lung tumors. "We feel that lung RFA could become more prevalent, first for patients who are not candidates for surgery, but also as an alternative to surgery for operable primary lung tumors, as long as the tumor is not too large.”


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Pressure Guidewire
SavvyWire
Digital Color Doppler Ultrasound System
MS22Plus
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.